Following this line, image-and coordinate-based

meta-analyses as well as data-sharing approaches are currently becoming increasingly important in imaging neuroscience. We would argue that this approach may provide a better capture of true effects in the underlying population as more conservative thresholding in an individual study. Nevertheless, we acknowledge that a formal correction for type II error within each individual Inhibitors,research,lifescience,medical study is highly advantageous if the effects are robust enough. Although our sample consisted of populations that could potentially differ in the frequency of the risk allele due to a different ethnical background, we did not Inhibitors,research,lifescience,medical genotype the sample for ancestry informative markers. Consequently, effects of ancestry could have led to

additional variance in our data. We included both male and female subjects in this study. Although gender was used as a covariate, a direct comparison between male and female T allele carriers would be interesting. However, the number of subjects included does not allow such a comparison. Future studies enrolling larger populations Inhibitors,research,lifescience,medical should also focus on gender-specific effects. In summary, we found both clusters of elevated and reduced FA in NRG1 rs35753505 C allele risk type carriers. Changes were most pronounced in the right perihippocampal region, where risk type carriers showed elevated FA values. The structural alterations described might in part be responsible for

differences in BOLD response found by functional imaging studies in a largely overlapping population Inhibitors,research,lifescience,medical (Krug et Inhibitors,research,lifescience,medical al. 2008b, 2010; Cabozantinib cancer Kircher et al. 2009b). Acknowledgments We acknowledge funding by the DFG (IRTG 1328, T. N. J., F. S., U. H.). Conflict of Interest None declared. Funding Information We acknowledge funding by the DFG (IRTG 1328, T. N. J., F. S., U. H.).
Impaired self-awareness, that is, an inaccurate subjective evaluation of one’s trait or state relative to a more objective measurement, has been reported in various neuropsychiatric or disorders, including neurodegenerative diseases (Orfei et al. 2008). It can involve the inadequate awareness of one’s disease state (disease unawareness) or focally impaired self-reflective abilities in a specific modality, AV-951 such as body sensation, various domains of cognition, or one’s characteristic traits and attitudes (modality-specific unawareness) (Clare 2004b; Ecklund-Johnson and Torres 2005; David et al. 2012). These specific modes of self-awareness, and the objective evidence against which one’s subjective self-evaluation is compared, are on a continuum from simple and concrete to highly abstract.